BioCentury
ARTICLE | Company News

Santhera Pharmaceuticals AG board of directors update

September 13, 2004 7:00 AM UTC

Santhera Pharmaceuticals AG, Liestal, Switzerland Business: Musculoskeletal, Metabolic, Functional genomics Appointed: Mark Clement, CEO of Merlin BioSciences; Ruedi Gygax, managing director of Novart...